Genetic variation in antioxidant enzymes and lung function

Amy R. Bentley, Stephen B. Kritchevsky, Tamara B. Harris, Anne B. Newman, Douglas C. Bauer, Bernd Meibohm, Andrew G. Clark, Patricia A. Cassano

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Not all cigarette smokers develop chronic obstructive pulmonary disease, and discovering susceptibility factors is an important research priority. The oxidative burden of smoking may overwhelm antioxidant defenses, and vulnerabilities may exist as a result of sequence variants in genes encoding antioxidant enzymes. This study explored the association between genetic variation in a network of antioxidant enzymes and lung phenotypes. Linear models evaluated single-locus marker associations in 2387 European American and African American participants in the Health, Aging, and Body Composition Study. After corrections were made for multiple comparisons, 15 statistically significant associations were identified, all of which were for SNP by smoking interactions. The most statistically significant findings were for genes encoding members of the isocitrate dehydrogenase gene family (IDH3A, IDH3B, IDH2). For rs6107100 (IDH3B) the variant genotype was associated with a difference of 6% in the FEV 1/FVC ratio in African American current smokers, but the SNP had little or no association with FEV 1/FVC in former and never smokers (nominal p interaction = 5 × 10 - 6). A variant of the peroxiredoxin gene (rs9787810, PRDX5) was associated with lower percentage predicted FEV 1 and a lower ratio in European American current smokers, with little or no association in other smoking groups (nominal p interaction = 0.0001 and 0.0003, respectively). The studied genes have not been reported in previous candidate gene association studies, and thus the findings suggest novel mechanisms and targets for future research and provide evidence for a contribution of sequence variation in genes encoding antioxidant enzymes to susceptibility in smokers.

Original languageEnglish (US)
Pages (from-to)1577-1583
Number of pages7
JournalFree Radical Biology and Medicine
Volume52
Issue number9
DOIs
StatePublished - May 1 2012

Fingerprint

Gene encoding
Antioxidants
Genes
Association reactions
Lung
Enzymes
Smoking
Peroxiredoxins
Isocitrate Dehydrogenase
African Americans
Pulmonary diseases
Single Nucleotide Polymorphism
Tobacco Products
Aging of materials
Disease Susceptibility
Health
Genetic Association Studies
Body Composition
Chronic Obstructive Pulmonary Disease
Linear Models

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Physiology (medical)

Cite this

Bentley, A. R., Kritchevsky, S. B., Harris, T. B., Newman, A. B., Bauer, D. C., Meibohm, B., ... Cassano, P. A. (2012). Genetic variation in antioxidant enzymes and lung function. Free Radical Biology and Medicine, 52(9), 1577-1583. https://doi.org/10.1016/j.freeradbiomed.2012.02.025

Genetic variation in antioxidant enzymes and lung function. / Bentley, Amy R.; Kritchevsky, Stephen B.; Harris, Tamara B.; Newman, Anne B.; Bauer, Douglas C.; Meibohm, Bernd; Clark, Andrew G.; Cassano, Patricia A.

In: Free Radical Biology and Medicine, Vol. 52, No. 9, 01.05.2012, p. 1577-1583.

Research output: Contribution to journalArticle

Bentley, AR, Kritchevsky, SB, Harris, TB, Newman, AB, Bauer, DC, Meibohm, B, Clark, AG & Cassano, PA 2012, 'Genetic variation in antioxidant enzymes and lung function', Free Radical Biology and Medicine, vol. 52, no. 9, pp. 1577-1583. https://doi.org/10.1016/j.freeradbiomed.2012.02.025
Bentley, Amy R. ; Kritchevsky, Stephen B. ; Harris, Tamara B. ; Newman, Anne B. ; Bauer, Douglas C. ; Meibohm, Bernd ; Clark, Andrew G. ; Cassano, Patricia A. / Genetic variation in antioxidant enzymes and lung function. In: Free Radical Biology and Medicine. 2012 ; Vol. 52, No. 9. pp. 1577-1583.
@article{1ca1edc881dd4f33959f0318e9848205,
title = "Genetic variation in antioxidant enzymes and lung function",
abstract = "Not all cigarette smokers develop chronic obstructive pulmonary disease, and discovering susceptibility factors is an important research priority. The oxidative burden of smoking may overwhelm antioxidant defenses, and vulnerabilities may exist as a result of sequence variants in genes encoding antioxidant enzymes. This study explored the association between genetic variation in a network of antioxidant enzymes and lung phenotypes. Linear models evaluated single-locus marker associations in 2387 European American and African American participants in the Health, Aging, and Body Composition Study. After corrections were made for multiple comparisons, 15 statistically significant associations were identified, all of which were for SNP by smoking interactions. The most statistically significant findings were for genes encoding members of the isocitrate dehydrogenase gene family (IDH3A, IDH3B, IDH2). For rs6107100 (IDH3B) the variant genotype was associated with a difference of 6{\%} in the FEV 1/FVC ratio in African American current smokers, but the SNP had little or no association with FEV 1/FVC in former and never smokers (nominal p interaction = 5 × 10 - 6). A variant of the peroxiredoxin gene (rs9787810, PRDX5) was associated with lower percentage predicted FEV 1 and a lower ratio in European American current smokers, with little or no association in other smoking groups (nominal p interaction = 0.0001 and 0.0003, respectively). The studied genes have not been reported in previous candidate gene association studies, and thus the findings suggest novel mechanisms and targets for future research and provide evidence for a contribution of sequence variation in genes encoding antioxidant enzymes to susceptibility in smokers.",
author = "Bentley, {Amy R.} and Kritchevsky, {Stephen B.} and Harris, {Tamara B.} and Newman, {Anne B.} and Bauer, {Douglas C.} and Bernd Meibohm and Clark, {Andrew G.} and Cassano, {Patricia A.}",
year = "2012",
month = "5",
day = "1",
doi = "10.1016/j.freeradbiomed.2012.02.025",
language = "English (US)",
volume = "52",
pages = "1577--1583",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Genetic variation in antioxidant enzymes and lung function

AU - Bentley, Amy R.

AU - Kritchevsky, Stephen B.

AU - Harris, Tamara B.

AU - Newman, Anne B.

AU - Bauer, Douglas C.

AU - Meibohm, Bernd

AU - Clark, Andrew G.

AU - Cassano, Patricia A.

PY - 2012/5/1

Y1 - 2012/5/1

N2 - Not all cigarette smokers develop chronic obstructive pulmonary disease, and discovering susceptibility factors is an important research priority. The oxidative burden of smoking may overwhelm antioxidant defenses, and vulnerabilities may exist as a result of sequence variants in genes encoding antioxidant enzymes. This study explored the association between genetic variation in a network of antioxidant enzymes and lung phenotypes. Linear models evaluated single-locus marker associations in 2387 European American and African American participants in the Health, Aging, and Body Composition Study. After corrections were made for multiple comparisons, 15 statistically significant associations were identified, all of which were for SNP by smoking interactions. The most statistically significant findings were for genes encoding members of the isocitrate dehydrogenase gene family (IDH3A, IDH3B, IDH2). For rs6107100 (IDH3B) the variant genotype was associated with a difference of 6% in the FEV 1/FVC ratio in African American current smokers, but the SNP had little or no association with FEV 1/FVC in former and never smokers (nominal p interaction = 5 × 10 - 6). A variant of the peroxiredoxin gene (rs9787810, PRDX5) was associated with lower percentage predicted FEV 1 and a lower ratio in European American current smokers, with little or no association in other smoking groups (nominal p interaction = 0.0001 and 0.0003, respectively). The studied genes have not been reported in previous candidate gene association studies, and thus the findings suggest novel mechanisms and targets for future research and provide evidence for a contribution of sequence variation in genes encoding antioxidant enzymes to susceptibility in smokers.

AB - Not all cigarette smokers develop chronic obstructive pulmonary disease, and discovering susceptibility factors is an important research priority. The oxidative burden of smoking may overwhelm antioxidant defenses, and vulnerabilities may exist as a result of sequence variants in genes encoding antioxidant enzymes. This study explored the association between genetic variation in a network of antioxidant enzymes and lung phenotypes. Linear models evaluated single-locus marker associations in 2387 European American and African American participants in the Health, Aging, and Body Composition Study. After corrections were made for multiple comparisons, 15 statistically significant associations were identified, all of which were for SNP by smoking interactions. The most statistically significant findings were for genes encoding members of the isocitrate dehydrogenase gene family (IDH3A, IDH3B, IDH2). For rs6107100 (IDH3B) the variant genotype was associated with a difference of 6% in the FEV 1/FVC ratio in African American current smokers, but the SNP had little or no association with FEV 1/FVC in former and never smokers (nominal p interaction = 5 × 10 - 6). A variant of the peroxiredoxin gene (rs9787810, PRDX5) was associated with lower percentage predicted FEV 1 and a lower ratio in European American current smokers, with little or no association in other smoking groups (nominal p interaction = 0.0001 and 0.0003, respectively). The studied genes have not been reported in previous candidate gene association studies, and thus the findings suggest novel mechanisms and targets for future research and provide evidence for a contribution of sequence variation in genes encoding antioxidant enzymes to susceptibility in smokers.

UR - http://www.scopus.com/inward/record.url?scp=84858991769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858991769&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2012.02.025

DO - 10.1016/j.freeradbiomed.2012.02.025

M3 - Article

C2 - 22387199

AN - SCOPUS:84858991769

VL - 52

SP - 1577

EP - 1583

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

IS - 9

ER -